Cardiovasc Diabetol

Probing erythrocytes as sensitive and reliable sensors of metabolic disturbances in the crosstalk between childhood obesity and insulin resistance: findings from an observational study, in vivo challenge tests, and ex vivo incubation assays.

González-Domínguez Á, Savolainen O, Domínguez-Riscart J, ..., Lechuga-Sancho A, González-Domínguez R

Cardiovasc Diabetol 23 (1) 336 [2024-09-11; online 2024-09-11]

Chalmers Mass Spectrometry Infrastructure [Collaborative]

Identifying metabotypes of insulin resistance severity in children with metabolic syndrome.

González-Domínguez Á, Domínguez-Riscart J, Savolainen O, ..., Landberg R, González-Domínguez R

Cardiovasc Diabetol 23 (1) 315 [2024-08-27; online 2024-08-27]

Chalmers Mass Spectrometry Infrastructure [Collaborative]

Galectin-4 levels in hospitalized versus non-hospitalized subjects with obesity: the Malmö Preventive Project.

Korduner J, Holm H, Jujic A, ..., Olsen MH, Magnusson M

Cardiovasc Diabetol 21 (1) 125 [2022-07-02; online 2022-07-02]

Affinity Proteomics Uppsala [Service]

Cardiovascular organ damage in type 2 diabetes mellitus: the role of lipids and inflammation.

Kozakova M, Morizzo C, Goncalves I, ..., Nilsson J, Palombo C

Cardiovasc Diabetol 18 (1) 61 [2019-05-10; online 2019-05-10]

Affinity Proteomics Uppsala [Service] Clinical Biomarkers [Service] PLA and Single Cell Proteomics [Service]